 | • レポートコード：QAF20831 • 出版社/出版日：QYResearch / 2021年5月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（即日納品） • 産業分類：化学＆材料 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のウシ血漿誘導体市場について種類別（ウシ血清、FBS、ウシ血清アルブミン、フィブリノーゲン、タンパク質成分、その他）、用途別（科学研究、工業生産、飼料、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ウシ血漿誘導体市場の概要 ・世界の主要地域別ウシ血漿誘導体市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のウシ血漿誘導体市場規模2016-2021：種類別（ウシ血清、FBS、ウシ血清アルブミン、フィブリノーゲン、タンパク質成分、その他） ・世界のウシ血漿誘導体市場予測2012-2027：種類別（ウシ血清、FBS、ウシ血清アルブミン、フィブリノーゲン、タンパク質成分、その他） ・世界のウシ血漿誘導体市場規模2016-2021：用途別（科学研究、工業生産、飼料、その他） ・世界のウシ血漿誘導体市場予測2012-2027：用途別（科学研究、工業生産、飼料、その他） ・ウシ血漿誘導体のアメリカ市場規模と予測2016-2021 ・ウシ血漿誘導体のヨーロッパ市場規模と予測2016-2021 ・ウシ血漿誘導体の中国市場規模と予測2016-2021 ・ウシ血漿誘導体の日本市場規模と予測2016-2021 ・ウシ血漿誘導体の東南アジア市場規模と予測2016-2021 ・ウシ血漿誘導体のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Thermo Fisher、GE Healthcare、Merck (Sigma-Aldrich)、Moregate BioTech、Gemini、Atlanta Biologicals、Tissue Culture Biologicals、Bovogen、Biowest、Internegocios、RMBIO、Biological Industries、VWR、Corning、Serana、Lanzhou Minhai、Zhejiang Tianhang Biotechnology、ExCell Bio、Jin Yuan Kang、American Protein Company、Sonac） ・ウシ血漿誘導体の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ウシ血漿誘導体の市場動向・機会・課題 ・調査の結論 |
Bovine Blood Plasma Derivatives covers different types of bovine blood plasma derivatives,and typically used in scientific research and industrial production.
Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals and Bovogen are major players in this market. Relying on blood supply from around the world, Thermo Fisher, GE Healthcare and Merck (Sigma-Aldrich) are the world’s three giants. In 2017, Merck (Sigma-Aldrich) is the world leader with a market share of 22.62%
Market Analysis and Insights: Global Bovine Blood Plasma Derivatives Market
The global Bovine Blood Plasma Derivatives market was valued at US$ 2024.3 in 2020 and will reach US$ 2636.2 million by the end of 2027, growing at a CAGR of 4.5% during 2022-2027.
Global Bovine Blood Plasma Derivatives Scope and Market Size
The global Bovine Blood Plasma Derivatives market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bovine Blood Plasma Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Bovine Serum
FBS
Bovine Serum Albumin
Fibrinogen
Protein Ingredient
Other
Segment by Application
Scientific Research
Industrial Production
Feed
Others
The Bovine Blood Plasma Derivatives market is analysed and market size information is provided by regions (countries). Segment by Application, the Bovine Blood Plasma Derivatives market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Thermo Fisher
GE Healthcare
Merck (Sigma-Aldrich)
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
VWR
Corning
Serana
Lanzhou Minhai
Zhejiang Tianhang Biotechnology
ExCell Bio
Jin Yuan Kang
American Protein Company
Sonac
1 Bovine Blood Plasma Derivatives Market Overview
1.1 Bovine Blood Plasma Derivatives Product Scope
1.2 Bovine Blood Plasma Derivatives Segment by Type
1.2.1 Global Bovine Blood Plasma Derivatives Sales by Type (2016 & 2021 & 2027)
1.2.2 Bovine Serum
1.2.3 FBS
1.2.4 Bovine Serum Albumin
1.2.5 Fibrinogen
1.2.6 Protein Ingredient
1.2.7 Other
1.3 Bovine Blood Plasma Derivatives Segment by Application
1.3.1 Global Bovine Blood Plasma Derivatives Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Scientific Research
1.3.3 Industrial Production
1.3.4 Feed
1.3.5 Others
1.4 Bovine Blood Plasma Derivatives Market Estimates and Forecasts (2016-2027)
1.4.1 Global Bovine Blood Plasma Derivatives Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Bovine Blood Plasma Derivatives Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Bovine Blood Plasma Derivatives Price Trends (2016-2027)
2 Bovine Blood Plasma Derivatives Estimates and Forecasts by Region
2.1 Global Bovine Blood Plasma Derivatives Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Bovine Blood Plasma Derivatives Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Bovine Blood Plasma Derivatives Sales Market Share by Region (2016-2021)
2.2.2 Global Bovine Blood Plasma Derivatives Revenue Market Share by Region (2016-2021)
2.3 Global Bovine Blood Plasma Derivatives Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Bovine Blood Plasma Derivatives Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Bovine Blood Plasma Derivatives Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Bovine Blood Plasma Derivatives Estimates and Projections (2016-2027)
2.4.2 Europe Bovine Blood Plasma Derivatives Estimates and Projections (2016-2027)
2.4.3 China Bovine Blood Plasma Derivatives Estimates and Projections (2016-2027)
2.4.4 Japan Bovine Blood Plasma Derivatives Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Bovine Blood Plasma Derivatives Estimates and Projections (2016-2027)
2.4.6 India Bovine Blood Plasma Derivatives Estimates and Projections (2016-2027)
3 Global Bovine Blood Plasma Derivatives Competition Landscape by Players
3.1 Global Top Bovine Blood Plasma Derivatives Players by Sales (2016-2021)
3.2 Global Top Bovine Blood Plasma Derivatives Players by Revenue (2016-2021)
3.3 Global Bovine Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bovine Blood Plasma Derivatives as of 2020)
3.4 Global Bovine Blood Plasma Derivatives Average Price by Company (2016-2021)
3.5 Manufacturers Bovine Blood Plasma Derivatives Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Bovine Blood Plasma Derivatives Market Size by Type
4.1 Global Bovine Blood Plasma Derivatives Historic Market Review by Type (2016-2021)
4.1.1 Global Bovine Blood Plasma Derivatives Sales Market Share by Type (2016-2021)
4.1.2 Global Bovine Blood Plasma Derivatives Revenue Market Share by Type (2016-2021)
4.1.3 Global Bovine Blood Plasma Derivatives Price by Type (2016-2021)
4.2 Global Bovine Blood Plasma Derivatives Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Bovine Blood Plasma Derivatives Sales Forecast by Type (2022-2027)
4.2.2 Global Bovine Blood Plasma Derivatives Revenue Forecast by Type (2022-2027)
4.2.3 Global Bovine Blood Plasma Derivatives Price Forecast by Type (2022-2027)
5 Global Bovine Blood Plasma Derivatives Market Size by Application
5.1 Global Bovine Blood Plasma Derivatives Historic Market Review by Application (2016-2021)
5.1.1 Global Bovine Blood Plasma Derivatives Sales Market Share by Application (2016-2021)
5.1.2 Global Bovine Blood Plasma Derivatives Revenue Market Share by Application (2016-2021)
5.1.3 Global Bovine Blood Plasma Derivatives Price by Application (2016-2021)
5.2 Global Bovine Blood Plasma Derivatives Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Bovine Blood Plasma Derivatives Sales Forecast by Application (2022-2027)
5.2.2 Global Bovine Blood Plasma Derivatives Revenue Forecast by Application (2022-2027)
5.2.3 Global Bovine Blood Plasma Derivatives Price Forecast by Application (2022-2027)
6 North America Bovine Blood Plasma Derivatives Market Facts & Figures
6.1 North America Bovine Blood Plasma Derivatives Sales by Company
6.1.1 North America Bovine Blood Plasma Derivatives Sales by Company (2016-2021)
6.1.2 North America Bovine Blood Plasma Derivatives Revenue by Company (2016-2021)
6.2 North America Bovine Blood Plasma Derivatives Sales Breakdown by Type
6.2.1 North America Bovine Blood Plasma Derivatives Sales Breakdown by Type (2016-2021)
6.2.2 North America Bovine Blood Plasma Derivatives Sales Breakdown by Type (2022-2027)
6.3 North America Bovine Blood Plasma Derivatives Sales Breakdown by Application
6.3.1 North America Bovine Blood Plasma Derivatives Sales Breakdown by Application (2016-2021)
6.3.2 North America Bovine Blood Plasma Derivatives Sales Breakdown by Application (2022-2027)
7 Europe Bovine Blood Plasma Derivatives Market Facts & Figures
7.1 Europe Bovine Blood Plasma Derivatives Sales by Company
7.1.1 Europe Bovine Blood Plasma Derivatives Sales by Company (2016-2021)
7.1.2 Europe Bovine Blood Plasma Derivatives Revenue by Company (2016-2021)
7.2 Europe Bovine Blood Plasma Derivatives Sales Breakdown by Type
7.2.1 Europe Bovine Blood Plasma Derivatives Sales Breakdown by Type (2016-2021)
7.2.2 Europe Bovine Blood Plasma Derivatives Sales Breakdown by Type (2022-2027)
7.3 Europe Bovine Blood Plasma Derivatives Sales Breakdown by Application
7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)
8 China Bovine Blood Plasma Derivatives Market Facts & Figures
8.1 China Bovine Blood Plasma Derivatives Sales by Company
8.1.1 China Bovine Blood Plasma Derivatives Sales by Company (2016-2021)
8.1.2 China Bovine Blood Plasma Derivatives Revenue by Company (2016-2021)
8.2 China Bovine Blood Plasma Derivatives Sales Breakdown by Type
8.2.1 China Bovine Blood Plasma Derivatives Sales Breakdown by Type (2016-2021)
8.2.2 China Bovine Blood Plasma Derivatives Sales Breakdown by Type (2022-2027)
8.3 China Bovine Blood Plasma Derivatives Sales Breakdown by Application
8.3.1 China 318 Sales Breakdown by Application (2016-2021)
8.3.2 China 318 Sales Breakdown by Application (2022-2027)
9 Japan Bovine Blood Plasma Derivatives Market Facts & Figures
9.1 Japan Bovine Blood Plasma Derivatives Sales by Company
9.1.1 Japan Bovine Blood Plasma Derivatives Sales by Company (2016-2021)
9.1.2 Japan Bovine Blood Plasma Derivatives Revenue by Company (2016-2021)
9.2 Japan Bovine Blood Plasma Derivatives Sales Breakdown by Type
9.2.1 Japan Bovine Blood Plasma Derivatives Sales Breakdown by Type (2016-2021)
9.2.2 Japan Bovine Blood Plasma Derivatives Sales Breakdown by Type (2022-2027)
9.3 Japan Bovine Blood Plasma Derivatives Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Bovine Blood Plasma Derivatives Market Facts & Figures
10.1 Southeast Asia Bovine Blood Plasma Derivatives Sales by Company
10.1.1 Southeast Asia Bovine Blood Plasma Derivatives Sales by Company (2016-2021)
10.1.2 Southeast Asia Bovine Blood Plasma Derivatives Revenue by Company (2016-2021)
10.2 Southeast Asia Bovine Blood Plasma Derivatives Sales Breakdown by Type
10.2.1 Southeast Asia Bovine Blood Plasma Derivatives Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Bovine Blood Plasma Derivatives Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Bovine Blood Plasma Derivatives Sales Breakdown by Application
10.3.1 Southeast Asia L Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia L Sales Breakdown by Application (2022-2027)
11 India Bovine Blood Plasma Derivatives Market Facts & Figures
11.1 India Bovine Blood Plasma Derivatives Sales by Company
11.1.1 India Bovine Blood Plasma Derivatives Sales by Company (2016-2021)
11.1.2 India Bovine Blood Plasma Derivatives Revenue by Company (2016-2021)
11.2 India Bovine Blood Plasma Derivatives Sales Breakdown by Type
11.2.1 India Bovine Blood Plasma Derivatives Sales Breakdown by Type (2016-2021)
11.2.2 India Bovine Blood Plasma Derivatives Sales Breakdown by Type (2022-2027)
11.3 India Bovine Blood Plasma Derivatives Sales Breakdown by Application
11.3.1 India Bovine Blood Plasma Derivatives Sales Breakdown by Application (2016-2021)
11.3.2 India Bovine Blood Plasma Derivatives Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Bovine Blood Plasma Derivatives Business
12.1 Thermo Fisher
12.1.1 Thermo Fisher Corporation Information
12.1.2 Thermo Fisher Business Overview
12.1.3 Thermo Fisher Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Thermo Fisher Bovine Blood Plasma Derivatives Products Offered
12.1.5 Thermo Fisher Recent Development
12.2 GE Healthcare
12.2.1 GE Healthcare Corporation Information
12.2.2 GE Healthcare Business Overview
12.2.3 GE Healthcare Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GE Healthcare Bovine Blood Plasma Derivatives Products Offered
12.2.5 GE Healthcare Recent Development
12.3 Merck (Sigma-Aldrich)
12.3.1 Merck (Sigma-Aldrich) Corporation Information
12.3.2 Merck (Sigma-Aldrich) Business Overview
12.3.3 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Products Offered
12.3.5 Merck (Sigma-Aldrich) Recent Development
12.4 Moregate BioTech
12.4.1 Moregate BioTech Corporation Information
12.4.2 Moregate BioTech Business Overview
12.4.3 Moregate BioTech Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Moregate BioTech Bovine Blood Plasma Derivatives Products Offered
12.4.5 Moregate BioTech Recent Development
12.5 Gemini
12.5.1 Gemini Corporation Information
12.5.2 Gemini Business Overview
12.5.3 Gemini Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Gemini Bovine Blood Plasma Derivatives Products Offered
12.5.5 Gemini Recent Development
12.6 Atlanta Biologicals
12.6.1 Atlanta Biologicals Corporation Information
12.6.2 Atlanta Biologicals Business Overview
12.6.3 Atlanta Biologicals Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Atlanta Biologicals Bovine Blood Plasma Derivatives Products Offered
12.6.5 Atlanta Biologicals Recent Development
12.7 Tissue Culture Biologicals
12.7.1 Tissue Culture Biologicals Corporation Information
12.7.2 Tissue Culture Biologicals Business Overview
12.7.3 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Products Offered
12.7.5 Tissue Culture Biologicals Recent Development
12.8 Bovogen
12.8.1 Bovogen Corporation Information
12.8.2 Bovogen Business Overview
12.8.3 Bovogen Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bovogen Bovine Blood Plasma Derivatives Products Offered
12.8.5 Bovogen Recent Development
12.9 Biowest
12.9.1 Biowest Corporation Information
12.9.2 Biowest Business Overview
12.9.3 Biowest Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Biowest Bovine Blood Plasma Derivatives Products Offered
12.9.5 Biowest Recent Development
12.10 Internegocios
12.10.1 Internegocios Corporation Information
12.10.2 Internegocios Business Overview
12.10.3 Internegocios Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Internegocios Bovine Blood Plasma Derivatives Products Offered
12.10.5 Internegocios Recent Development
12.11 RMBIO
12.11.1 RMBIO Corporation Information
12.11.2 RMBIO Business Overview
12.11.3 RMBIO Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.11.4 RMBIO Bovine Blood Plasma Derivatives Products Offered
12.11.5 RMBIO Recent Development
12.12 Biological Industries
12.12.1 Biological Industries Corporation Information
12.12.2 Biological Industries Business Overview
12.12.3 Biological Industries Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Biological Industries Bovine Blood Plasma Derivatives Products Offered
12.12.5 Biological Industries Recent Development
12.13 VWR
12.13.1 VWR Corporation Information
12.13.2 VWR Business Overview
12.13.3 VWR Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.13.4 VWR Bovine Blood Plasma Derivatives Products Offered
12.13.5 VWR Recent Development
12.14 Corning
12.14.1 Corning Corporation Information
12.14.2 Corning Business Overview
12.14.3 Corning Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Corning Bovine Blood Plasma Derivatives Products Offered
12.14.5 Corning Recent Development
12.15 Serana
12.15.1 Serana Corporation Information
12.15.2 Serana Business Overview
12.15.3 Serana Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Serana Bovine Blood Plasma Derivatives Products Offered
12.15.5 Serana Recent Development
12.16 Lanzhou Minhai
12.16.1 Lanzhou Minhai Corporation Information
12.16.2 Lanzhou Minhai Business Overview
12.16.3 Lanzhou Minhai Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Lanzhou Minhai Bovine Blood Plasma Derivatives Products Offered
12.16.5 Lanzhou Minhai Recent Development
12.17 Zhejiang Tianhang Biotechnology
12.17.1 Zhejiang Tianhang Biotechnology Corporation Information
12.17.2 Zhejiang Tianhang Biotechnology Business Overview
12.17.3 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Products Offered
12.17.5 Zhejiang Tianhang Biotechnology Recent Development
12.18 ExCell Bio
12.18.1 ExCell Bio Corporation Information
12.18.2 ExCell Bio Business Overview
12.18.3 ExCell Bio Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.18.4 ExCell Bio Bovine Blood Plasma Derivatives Products Offered
12.18.5 ExCell Bio Recent Development
12.19 Jin Yuan Kang
12.19.1 Jin Yuan Kang Corporation Information
12.19.2 Jin Yuan Kang Business Overview
12.19.3 Jin Yuan Kang Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Jin Yuan Kang Bovine Blood Plasma Derivatives Products Offered
12.19.5 Jin Yuan Kang Recent Development
12.20 American Protein Company
12.20.1 American Protein Company Corporation Information
12.20.2 American Protein Company Business Overview
12.20.3 American Protein Company Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.20.4 American Protein Company Bovine Blood Plasma Derivatives Products Offered
12.20.5 American Protein Company Recent Development
12.21 Sonac
12.21.1 Sonac Corporation Information
12.21.2 Sonac Business Overview
12.21.3 Sonac Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Sonac Bovine Blood Plasma Derivatives Products Offered
12.21.5 Sonac Recent Development
13 Bovine Blood Plasma Derivatives Manufacturing Cost Analysis
13.1 Bovine Blood Plasma Derivatives Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Bovine Blood Plasma Derivatives
13.4 Bovine Blood Plasma Derivatives Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Bovine Blood Plasma Derivatives Distributors List
14.3 Bovine Blood Plasma Derivatives Customers
15 Market Dynamics
15.1 Bovine Blood Plasma Derivatives Market Trends
15.2 Bovine Blood Plasma Derivatives Drivers
15.3 Bovine Blood Plasma Derivatives Market Challenges
15.4 Bovine Blood Plasma Derivatives Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Bovine Blood Plasma Derivatives Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Bovine Blood Plasma Derivatives Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Bovine Blood Plasma Derivatives Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Bovine Blood Plasma Derivatives Sales (L) by Region (2016-2021)
Table 5. Global Bovine Blood Plasma Derivatives Sales Market Share by Region (2016-2021)
Table 6. Global Bovine Blood Plasma Derivatives Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Bovine Blood Plasma Derivatives Revenue Share by Region (2016-2021)
Table 8. Global Bovine Blood Plasma Derivatives Sales (L) Forecast by Region (2022-2027)
Table 9. Global Bovine Blood Plasma Derivatives Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Bovine Blood Plasma Derivatives Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Bovine Blood Plasma Derivatives Revenue Share Forecast by Region (2022-2027)
Table 12. Global Bovine Blood Plasma Derivatives Sales (L) of Key Companies (2016-2021)
Table 13. Global Bovine Blood Plasma Derivatives Sales Share by Company (2016-2021)
Table 14. Global Bovine Blood Plasma Derivatives Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Bovine Blood Plasma Derivatives Revenue Share by Company (2016-2021)
Table 16. Global Bovine Blood Plasma Derivatives by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bovine Blood Plasma Derivatives as of 2020)
Table 17. Global Bovine Blood Plasma Derivatives Average Price (USD/L) of Key Company (2016-2021)
Table 18. Manufacturers Bovine Blood Plasma Derivatives Manufacturing Sites and Area Served
Table 19. Manufacturers Bovine Blood Plasma Derivatives Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Bovine Blood Plasma Derivatives Sales (L) by Type (2016-2021)
Table 22. Global Bovine Blood Plasma Derivatives Sales Share by Type (2016-2021)
Table 23. Global Bovine Blood Plasma Derivatives Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Bovine Blood Plasma Derivatives Price (USD/L) by Type (2016-2021)
Table 25. Global Bovine Blood Plasma Derivatives Sales Share by Type (2022-2027)
Table 26. Global Bovine Blood Plasma Derivatives Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Bovine Blood Plasma Derivatives Revenue Share by Type (2022-2027)
Table 28. Global Bovine Blood Plasma Derivatives Price (USD/L) by Type (2022-2027)
Table 29. Global Bovine Blood Plasma Derivatives Sales (L) by Application (2016-2021)
Table 30. Global Bovine Blood Plasma Derivatives Sales Share by Application (2016-2021)
Table 31. Global Bovine Blood Plasma Derivatives Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Bovine Blood Plasma Derivatives Price (USD/L) by Application (2016-2021)
Table 33. Global Bovine Blood Plasma Derivatives Sales (L) by Application (2022-2027)
Table 34. Global Bovine Blood Plasma Derivatives Sales Share by Application (2022-2027)
Table 35. Global Bovine Blood Plasma Derivatives Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Bovine Blood Plasma Derivatives Revenue Share by Application (2022-2027)
Table 37. Global Bovine Blood Plasma Derivatives Price (USD/L) by Application (2022-2027)
Table 38. North America Bovine Blood Plasma Derivatives Sales (L) by Company (2016-2021)
Table 39. North America Bovine Blood Plasma Derivatives Sales Market Share by Company (2016-2021)
Table 40. North America Bovine Blood Plasma Derivatives Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Bovine Blood Plasma Derivatives Revenue Market Share by Company (2016-2021)
Table 42. North America Bovine Blood Plasma Derivatives Sales by Type (2016-2021) & (L)
Table 43. North America Bovine Blood Plasma Derivatives Sales Market Share by Type (2016-2021)
Table 44. North America Bovine Blood Plasma Derivatives Sales by Type (2022-2027) & (L)
Table 45. North America Bovine Blood Plasma Derivatives Sales Market Share by Type (2022-2027)
Table 46. North America Bovine Blood Plasma Derivatives Sales by Application (2016-2021) & (L)
Table 47. North America Bovine Blood Plasma Derivatives Sales Market Share by Application (2016-2021)
Table 48. North America Bovine Blood Plasma Derivatives Sales by Application (2022-2027) & (L)
Table 49. North America Bovine Blood Plasma Derivatives Sales Market Share by Application (2022-2027)
Table 50. Europe Bovine Blood Plasma Derivatives Sales (L) by Company (2016-2021)
Table 51. Europe Bovine Blood Plasma Derivatives Sales Market Share by Company (2016-2021)
Table 52. Europe Bovine Blood Plasma Derivatives Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Bovine Blood Plasma Derivatives Revenue Market Share by Company (2016-2021)
Table 54. Europe Bovine Blood Plasma Derivatives Sales by Type (2016-2021) & (L)
Table 55. Europe Bovine Blood Plasma Derivatives Sales Market Share by Type (2016-2021)
Table 56. Europe Bovine Blood Plasma Derivatives Sales by Type (2022-2027) & (L)
Table 57. Europe Bovine Blood Plasma Derivatives Sales Market Share by Type (2022-2027)
Table 58. Europe Bovine Blood Plasma Derivatives Sales by Application (2016-2021) & (L)
Table 59. Europe Bovine Blood Plasma Derivatives Sales Market Share by Application (2016-2021)
Table 60. Europe Bovine Blood Plasma Derivatives Sales by Application (2022-2027) & (L)
Table 61. Europe Bovine Blood Plasma Derivatives Sales Market Share by Application (2022-2027)
Table 62. China Bovine Blood Plasma Derivatives Sales (L) by Company (2016-2021)
Table 63. China Bovine Blood Plasma Derivatives Sales Market Share by Company (2016-2021)
Table 64. China Bovine Blood Plasma Derivatives Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Bovine Blood Plasma Derivatives Revenue Market Share by Company (2016-2021)
Table 66. China Bovine Blood Plasma Derivatives Sales by Type (2016-2021) & (L)
Table 67. China Bovine Blood Plasma Derivatives Sales Market Share by Type (2016-2021)
Table 68. China Bovine Blood Plasma Derivatives Sales by Type (2022-2027) & (L)
Table 69. China Bovine Blood Plasma Derivatives Sales Market Share by Type (2022-2027)
Table 70. China Bovine Blood Plasma Derivatives Sales by Application (2016-2021) & (L)
Table 71. China Bovine Blood Plasma Derivatives Sales Market Share by Application (2016-2021)
Table 72. China Bovine Blood Plasma Derivatives Sales by Application (2022-2027) & (L)
Table 73. China Bovine Blood Plasma Derivatives Sales Market Share by Application (2022-2027)
Table 74. Japan Bovine Blood Plasma Derivatives Sales (L) by Company (2016-2021)
Table 75. Japan Bovine Blood Plasma Derivatives Sales Market Share by Company (2016-2021)
Table 76. Japan Bovine Blood Plasma Derivatives Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Bovine Blood Plasma Derivatives Revenue Market Share by Company (2016-2021)
Table 78. Japan Bovine Blood Plasma Derivatives Sales by Type (2016-2021) & (L)
Table 79. Japan Bovine Blood Plasma Derivatives Sales Market Share by Type (2016-2021)
Table 80. Japan Bovine Blood Plasma Derivatives Sales by Type (2022-2027) & (L)
Table 81. Japan Bovine Blood Plasma Derivatives Sales Market Share by Type (2022-2027)
Table 82. Japan Bovine Blood Plasma Derivatives Sales by Application (2016-2021) & (L)
Table 83. Japan Bovine Blood Plasma Derivatives Sales Market Share by Application (2016-2021)
Table 84. Japan Bovine Blood Plasma Derivatives Sales by Application (2022-2027) & (L)
Table 85. Japan Bovine Blood Plasma Derivatives Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Bovine Blood Plasma Derivatives Sales (L) by Company (2016-2021)
Table 87. Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Bovine Blood Plasma Derivatives Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Bovine Blood Plasma Derivatives Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Bovine Blood Plasma Derivatives Sales by Type (2016-2021) & (L)
Table 91. Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Bovine Blood Plasma Derivatives Sales by Type (2022-2027) & (L)
Table 93. Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Bovine Blood Plasma Derivatives Sales by Application (2016-2021) & (L)
Table 95. Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Bovine Blood Plasma Derivatives Sales by Application (2022-2027) & (L)
Table 97. Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Application (2022-2027)
Table 98. India Bovine Blood Plasma Derivatives Sales (L) by Company (2016-2021)
Table 99. India Bovine Blood Plasma Derivatives Sales Market Share by Company (2016-2021)
Table 100. India Bovine Blood Plasma Derivatives Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Bovine Blood Plasma Derivatives Revenue Market Share by Company (2016-2021)
Table 102. India Bovine Blood Plasma Derivatives Sales by Type (2016-2021) & (L)
Table 103. India Bovine Blood Plasma Derivatives Sales Market Share by Type (2016-2021)
Table 104. India Bovine Blood Plasma Derivatives Sales by Type (2022-2027) & (L)
Table 105. India Bovine Blood Plasma Derivatives Sales Market Share by Type (2022-2027)
Table 106. India Bovine Blood Plasma Derivatives Sales by Application (2016-2021) & (L)
Table 107. India Bovine Blood Plasma Derivatives Sales Market Share by Application (2016-2021)
Table 108. India Bovine Blood Plasma Derivatives Sales by Application (2022-2027) & (L)
Table 109. India Bovine Blood Plasma Derivatives Sales Market Share by Application (2022-2027)
Table 110. Thermo Fisher Corporation Information
Table 111. Thermo Fisher Description and Business Overview
Table 112. Thermo Fisher Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 113. Thermo Fisher Bovine Blood Plasma Derivatives Product
Table 114. Thermo Fisher Recent Development
Table 115. GE Healthcare Corporation Information
Table 116. GE Healthcare Description and Business Overview
Table 117. GE Healthcare Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 118. GE Healthcare Bovine Blood Plasma Derivatives Product
Table 119. GE Healthcare Recent Development
Table 120. Merck (Sigma-Aldrich) Corporation Information
Table 121. Merck (Sigma-Aldrich) Description and Business Overview
Table 122. Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 123. Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Product
Table 124. Merck (Sigma-Aldrich) Recent Development
Table 125. Moregate BioTech Corporation Information
Table 126. Moregate BioTech Description and Business Overview
Table 127. Moregate BioTech Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 128. Moregate BioTech Bovine Blood Plasma Derivatives Product
Table 129. Moregate BioTech Recent Development
Table 130. Gemini Corporation Information
Table 131. Gemini Description and Business Overview
Table 132. Gemini Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 133. Gemini Bovine Blood Plasma Derivatives Product
Table 134. Gemini Recent Development
Table 135. Atlanta Biologicals Corporation Information
Table 136. Atlanta Biologicals Description and Business Overview
Table 137. Atlanta Biologicals Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 138. Atlanta Biologicals Bovine Blood Plasma Derivatives Product
Table 139. Atlanta Biologicals Recent Development
Table 140. Tissue Culture Biologicals Corporation Information
Table 141. Tissue Culture Biologicals Description and Business Overview
Table 142. Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 143. Tissue Culture Biologicals Bovine Blood Plasma Derivatives Product
Table 144. Tissue Culture Biologicals Recent Development
Table 145. Bovogen Corporation Information
Table 146. Bovogen Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 147. Bovogen Description and Business Overview
Table 148. Bovogen Bovine Blood Plasma Derivatives Product
Table 149. Bovogen Recent Development
Table 150. Biowest Corporation Information
Table 151. Biowest Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 152. Biowest Description and Business Overview
Table 153. Biowest Bovine Blood Plasma Derivatives Product
Table 154. Biowest Recent Development
Table 155. Internegocios Corporation Information
Table 156. Internegocios Description and Business Overview
Table 157. Internegocios Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 158. Internegocios Bovine Blood Plasma Derivatives Product
Table 159. Internegocios Recent Development
Table 160. RMBIO Corporation Information
Table 161. RMBIO Description and Business Overview
Table 162. RMBIO Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 163. RMBIO Bovine Blood Plasma Derivatives Product
Table 164. RMBIO Recent Development
Table 165. Biological Industries Corporation Information
Table 166. Biological Industries Description and Business Overview
Table 167. Biological Industries Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 168. Biological Industries Bovine Blood Plasma Derivatives Product
Table 169. Biological Industries Recent Development
Table 170. VWR Corporation Information
Table 171. VWR Description and Business Overview
Table 172. VWR Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 173. VWR Bovine Blood Plasma Derivatives Product
Table 174. VWR Recent Development
Table 175. Corning Corporation Information
Table 176. Corning Description and Business Overview
Table 177. Corning Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 178. Corning Bovine Blood Plasma Derivatives Product
Table 179. Corning Recent Development
Table 180. Serana Corporation Information
Table 181. Serana Description and Business Overview
Table 182. Serana Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 183. Serana Bovine Blood Plasma Derivatives Product
Table 184. Serana Recent Development
Table 185. Lanzhou Minhai Corporation Information
Table 186. Lanzhou Minhai Description and Business Overview
Table 187. Lanzhou Minhai Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 188. Lanzhou Minhai Bovine Blood Plasma Derivatives Product
Table 189. Lanzhou Minhai Recent Development
Table 190. Zhejiang Tianhang Biotechnology Corporation Information
Table 191. Zhejiang Tianhang Biotechnology Description and Business Overview
Table 192. Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 193. Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Product
Table 194. Zhejiang Tianhang Biotechnology Recent Development
Table 195. ExCell Bio Corporation Information
Table 196. ExCell Bio Description and Business Overview
Table 197. ExCell Bio Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 198. ExCell Bio Bovine Blood Plasma Derivatives Product
Table 199. ExCell Bio Recent Development
Table 200. Jin Yuan Kang Corporation Information
Table 201. Jin Yuan Kang Description and Business Overview
Table 202. Jin Yuan Kang Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 203. Jin Yuan Kang Bovine Blood Plasma Derivatives Product
Table 204. Jin Yuan Kang Recent Development
Table 205. American Protein Company Corporation Information
Table 206. American Protein Company Description and Business Overview
Table 207. American Protein Company Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 208. American Protein Company Bovine Blood Plasma Derivatives Product
Table 209. American Protein Company Recent Development
Table 210. Sonac Corporation Information
Table 211. Sonac Description and Business Overview
Table 212. Sonac Bovine Blood Plasma Derivatives Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 213. Sonac Bovine Blood Plasma Derivatives Product
Table 214. Sonac Recent Development
Table 215. Production Base and Market Concentration Rate of Raw Material
Table 216. Key Suppliers of Raw Materials
Table 217. Bovine Blood Plasma Derivatives Distributors List
Table 218. Bovine Blood Plasma Derivatives Customers List
Table 219. Bovine Blood Plasma Derivatives Market Trends
Table 220. Bovine Blood Plasma Derivatives Market Drivers
Table 221. Bovine Blood Plasma Derivatives Market Challenges
Table 222. Bovine Blood Plasma Derivatives Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Bovine Blood Plasma Derivatives Product Picture
Figure 2. Global Bovine Blood Plasma Derivatives Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Bovine Blood Plasma Derivatives Sales Market Share by Application in 2021 & 2027
Figure 6. Scientific Research Examples
Figure 7. Industrial Production Examples
Figure 8. Feed Examples
Figure 9. Others Examples
Figure 10. Global Bovine Blood Plasma Derivatives Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Bovine Blood Plasma Derivatives Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Bovine Blood Plasma Derivatives Sales (L) Growth Rate (2016-2027)
Figure 13. Global Bovine Blood Plasma Derivatives Price Trends Growth Rate (2016-2027) (USD/L)
Figure 14. Global Bovine Blood Plasma Derivatives Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Bovine Blood Plasma Derivatives Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Bovine Blood Plasma Derivatives Sales (L) Growth Rate (2016-2027)
Figure 18. Europe Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Bovine Blood Plasma Derivatives Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Bovine Blood Plasma Derivatives Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Bovine Blood Plasma Derivatives Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Bovine Blood Plasma Derivatives Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Bovine Blood Plasma Derivatives Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Bovine Blood Plasma Derivatives Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Bovine Blood Plasma Derivatives Players Market Share by Revenue in Bovine Blood Plasma Derivatives: 2016 & 2020
Figure 29. Bovine Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Bovine Blood Plasma Derivatives Revenue Share by Type (2016-2021)
Figure 31. Global Bovine Blood Plasma Derivatives Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Bovine Blood Plasma Derivatives Revenue Share by Application (2016-2021)
Figure 33. Global Bovine Blood Plasma Derivatives Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Bovine Blood Plasma Derivatives Sales Market Share by Type in 2020
Figure 35. North America Bovine Blood Plasma Derivatives Sales Market Share by Application in 2020
Figure 36. Europe Bovine Blood Plasma Derivatives Sales Market Share by Type in 2020
Figure 37. Europe Bovine Blood Plasma Derivatives Sales Market Share by Application in 2020
Figure 38. China Bovine Blood Plasma Derivatives Sales Market Share by Type in 2020
Figure 39. China Bovine Blood Plasma Derivatives Sales Market Share by Application in 2020
Figure 40. Japan Bovine Blood Plasma Derivatives Sales Market Share by Type in 2020
Figure 41. Japan Bovine Blood Plasma Derivatives Sales Market Share by Application in 2020
Figure 42. Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Type in 2020
Figure 43. Southeast Asia Bovine Blood Plasma Derivatives Sales Market Share by Application in 2020
Figure 44. India Bovine Blood Plasma Derivatives Sales Market Share by Type in 2020
Figure 45. India Bovine Blood Plasma Derivatives Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Bovine Blood Plasma Derivatives
Figure 48. Manufacturing Process Analysis of Bovine Blood Plasma Derivatives
Figure 49. Bovine Blood Plasma Derivatives Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed